Summary of research supporting pistachio’s health benefits
Health benefits | Type of study | Principals results | References |
---|---|---|---|
Antioxidant and anti-inflammatory potential | RCT: parallel-design study in healthy individuals, n = 44G1: regular diet, n = 22G2: regular diet + pistachios, n = 22 | ↑: AOP↓: MDA | [56] |
RCT: prospective study in healthy young men, n = 32 | ↑: SOD↓: TOS, MDA, LOOH, IL-6=: CRP, TNF-α | [57] | |
In vitro assay in macrophages cell line J774-A1 stimulated with LPS (from Escherichia coli 1.0 µg/mL) | ↓: TNF-α, IL-1β, NO, ROS, MDA, iNOS, COX-2 | [58] | |
In vivo assay with Sprague-Dawley male rats with paw edema induced by CAR, n = 30CAR: n = 10CAR + NP: n = 10CAR + RP: n = 10 | With NP↓: MPO, edema volume, number of inflammatory cellsNormal appearance of muscle fibersWith RPNo significant changes | [58] | |
Cardioprotective and antihypertensive effects | RCT: parallel-design study in healthy individuals. n = 44G1: regular diet, n = 22G2: regular diet + pistachios, n = 22 | ↑: HDL↓: TC=: LDL, TG | [56] |
RCT: prospective study in healthy young men, n = 32 | ↑: BAFMVD↓: LDL, TC, TG, CT/HDL, LDL/HDL=: HDL, blood pressure | [57] | |
RCT: parallel-design study in individuals with hyperlipemia, n = 56G1: regular diet, n = 27G2: regular diet + pistachios, n = 29 | ↑: HDL, BAFMVD↓: LDL, TC/HDL, PWV | [59] | |
In vitro assays: ACE enzyme inhibitory activity by pistachio peptides | ↓: confirmation of ACE inhibitory activity | [60] | |
Glycemic control and T2-DM | RCCT: Crossover clinical trial in prediabetic patients, n = 54 | ↓: glycemia, insulin, HOMA-IR, IL-18=: HbA1c | [61] |
RCT: Parallel-design study in individuals with hyperlipemia, n = 56G1: regular diet, n = 27G2: regular diet + pistachios. n = 29 | ↓: glycemia | [59] | |
RCCT: double-blind, placebo-controlled trial in prediabetic individuals, n = 48 | ↓: glycemia, HbA1c=: HOMA-IR | [62] | |
RCT: prospective study in healthy young men, n = 32 | ↓: blood glucose | [57] | |
RCT: patients with metabolic syndrome, n = 10 | ↓: glycemic index | [63] | |
In vitro assay: α-amylase and α-glucosidase enzymatic activity | ↓: α-amylase and α-glucosidase activity | [53] | |
Weight control | RCT: patients with obesity, n = 52 | ↓: BMI, body weight | [64] |
RCCT: Double-blind, placebo-controlled trial in prediabetic individuals | ↓: BMI | [62] | |
Gut microbiota modulation and antimicrobial effect | Animal’s trial: healthy rats and with T1-DMG1: Healthy animals + control diet, n = 6G2: Healthy animals + pistachio diet, n = 6G3: diabetic animals + control diet, n = 6G4: diabetic animals + pistachio diet, n = 6 | ↑: fecal lactobacilli and bifidobacterial irmicutes population in healthy animals, Bifidobacterium genus in diabetic rats↓: Bacteroidetes levels in healthy animals | [65] |
Animal’s trial: mice fed a HFDG1: control animals + standard diet, n = 8G2: obese animals + HFD, n = 8G3: obese animals + HFD+pistachio, n = 8 | ↑: Parabacteroides, Dorea, Allobaculum, Turicibacter, Lactobacillus, Anaeroplasma, Oscillospira, Desulfovibrio, Coprobacillus, Bilophila↓: Firmicutes/Bacteroidetes | [66] | |
RCCT: randomized cross-over, n = 16 | ↑: LAB=: Bifidobacterium | [67] | |
In vitro: antimicrobial potential of phenolic extracts from NP and RP. ATCC strains | ↑: bactericidal activity on L. monocytogenes, Staphylococcus (S.) aureus and Methicillin-resistant S. aureus strains (NP > RP) | [68] |
↑: increase; ↓: decrease; =: remains unchanged; n: number of individuals. RCT: randomized controlled trial; RCCT: randomized crossover clinical trial; AOP: antioxidant potencial; MDA: malonaldehyde; SOD: superoxide dismutase; TOS: total oxidant status; LOOH: lipid hydroperoxides; IL-6: interleukin-6; CRP: C-reactive protein; TNF-α: tumor necrosis factor-α; NO: nitric oxide; ROS: reactive oxygen species; iNOS: inducible NO synthetase; COX-2: cyclooxygenase-2; NP: natural pistachio; RP: roasted pistachio; LPS: lipopolysaccharide; CAR: carrageenan; MPO: myeloperoxidase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TC: total cholesterol; TG: triacyclglycerols; BAFMVD: brachial artery flow-mediated vasodilation; PWV: pulse wave velocity; ACE: angiotensin-converting enzyme; HOMA-IR: homeostasis model assessment of insulin resistance; HbA1c: glycated hemoglobin A1c; BMI: body mass index; HFD: high-fat diet; ATCC: American Type Culture Collection; LAB: lactic acid bacteria; T2-DM: type 2 diabetes mellitus